标普和纳斯达克内在价值 联系我们

Atrion Corporation ATRI NASDAQ

NASDAQ Global Select • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
52/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Atrion Corporation (ATRI) 当前追踪市盈率 (P/E) 为 41.7. 追踪盈利收益率为 2.40%.

本页证实的标准:

  • VALUE (15/100, 未通过) — 追踪市盈率远高于标普500平均值约25,表明估值偏高 (P/E 41.7).
  • 追踪盈利收益率 2.40% — 低于债券收益率 — 投资者为预期增长而非当前盈利支付溢价。

SharesGrow 综合评分: 52/100 其中 2/7 项标准通过。

SharesGrow 7-Criteria Score
52/100
SG Score
View full scorecard →
价值
15/100
Price-to-Earnings & upside
Proven by this page
未來
20/100
Analyst consensus
→ Forecast
过去
100/100
→ Income
健康
100/100
Debt-to-Equity & liquidity
→ Health
护城河
35/100
→ Income
~
成长
40/100
→ Income
~
收入
55/100
→ Income

估值概览 — ATRI

估值倍数
P/E (TTM)41.7
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率4.78
EV/EBITDA0.0
每股数据
EPS (TTM)$11.02
每股账面价值$0.00
每股营收$96.15
每股自由现金流$0.00
收益率与内在价值
盈利收益率2.40%
股息收益率0.00%

EPS:实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2014 $14.08 $140.76M $27.81M 19.8%
2015 $15.47 $145.73M $28.93M 19.8%
2016 $14.85 $143.49M $27.58M 19.2%
2017 $19.71 $146.6M $36.59M 25%
2018 $18.44 $152.45M $34.26M 22.5%
2019 $19.73 $155.07M $36.76M 23.7%
2020 $17.44 $147.59M $32.12M 21.8%
2021 $18.18 $165.01M $33.06M 20%
2022 $19.56 $183.51M $35.01M 19.1%
2023 $11.02 $169.33M $19.41M 11.5%
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言